January 22, 2024
Swedish therapeutic biotechnology company Anocca is preparing for a Series C funding round with a ticket size of at least SEK 800m - advisors were recently appointed, with the process expected to close after the summer 2024 (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights